Non-invasive Aesthetic Treatment Market Worth $18.5 Billion By 2028

The global Non-Invasive Aesthetic Treatment Market size is expected to reach USD 18.5 billion by 2028, according to a new report by Grand View Research, Inc., registering a CAGR of 13.9% over the forecast period. Non-invasive aesthetic treatment offer benefits, such as less pain, instant results, and low cost, over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging.

According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects for the market in the coming years. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.

Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. Asia Pacific is expected to be the fastest-growing regional market over the forecast period due to the rapidly growing population in countries, such as India and China.

Related Press Release@ Non-invasive Aesthetic Treatment Market Report

Non-invasive Aesthetic Treatment Market Report Highlights

• Injectable procedure is projected to be the leading procedure segment over the forecast period
• Among various injectable procedures, botulinum toxin is one of the most widely used minimally invasive treatment
• North America was the dominant regional market in 2020 accounting for a share of around 37% due to the availability and adoption of advanced treatment options in this region
• Asia Pacific is projected to register the fastest CAGR over the forecast period on account of the rising target population in the region